A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16390546

Download in:

View as

General Info

PMID
16390546